None
Quote | LogicBio Therapeutics Inc. (NASDAQ:LOGC)
Last: | $2.07 |
---|---|
Change Percent: | 0.48% |
Open: | $2.06 |
Close: | $2.07 |
High: | $2.07 |
Low: | $2.06 |
Volume: | 153,044 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | LogicBio Therapeutics Inc. (NASDAQ:LOGC)
LogicBio press release ( NASDAQ: LOGC ): Q3 GAAP EPS of -$0.18 beats by $0.02 . Revenue of $2.72M (+28.3% Y/Y) beats by $0.72M . Shares -0.48% PM. For further details see: LogicBio GAAP EPS of -$0.18 beats by $0.02, revenue of $2.72M beats by $0.7...
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates PR Newswire - Pre-clinical results published in PLOS ONE demonstrating a single intravenous administration of mLB-001 in neonatal or adult MMA mice correlated with preventi...
Message Board Posts | LogicBio Therapeutics Inc. (NASDAQ:LOGC)
Subject | By | Source | When |
---|---|---|---|
$LOGC: This shit ain't gonna lie DEAD at | Invest-in-America | investorshub | 10/07/2022 3:28:41 PM |
$LOGC: Circa $10.00-even was its IPO price, right | Invest-in-America | investorshub | 10/05/2022 8:21:58 PM |
$2.07 is the price unless you give them | subslover | investorshub | 10/05/2022 5:54:47 PM |
Why did it go up ten times the | phillymillions | investorshub | 10/05/2022 4:36:32 PM |
So why is this totally flat sideways | phillymillions | investorshub | 10/05/2022 4:31:18 PM |
News, Short Squeeze, Breakout and More Instantly...
LogicBio Therapeutics Inc. Company Name:
LOGC Stock Symbol:
NASDAQ Market:
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates PR Newswire - Pre-clinical results published in PLOS ONE demonstrating a single intravenous administration of mLB-001 in neonatal or adult MMA mice correlated with preventi...
NEW YORK, NY / ACCESSWIRE / October 20, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: KnowBe4, Inc. (NASDAQ:KNBE)'s s...
NEW YORK, NY / ACCESSWIRE / October 16, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: LogicBio Therapeutics, Inc. (NASD...